C-Reactive Protein as a Predictor of Cardiovascular Events and Mortality in Obstructive Sleep Apnea: A Propensity-Matched Analysis Using the TriNetX Research Network
Sleep science (Sao Paulo, Brazil), 11 Oct 2026
Osteoporosis medication initiation after proximal humerus fractures is low, but associated with decreased secondary fragility fracture risk
OTA international : the open access journal of orthopaedic trauma, 9 Oct 2026
Weight-loss surgery linked to lower dementia and Parkinson's risk
International journal of obesity (2005), 8 Oct 2026
Kidney Outcomes With GLP-1 Receptor Agonists and Tirzepatide Versus Finerenone in Type 2 Diabetes and Chronic Kidney Disease: A Real-World Cohort Study
Diabetes, obesity & metabolism, 8 Oct 2026
Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus
Journal of cardiovascular medicine (Hagerstown, Md.), 21 Sept 2026
Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study
International journal of cardiology, 16 Sept 2026
Predicting 5-Year Mortality After Prosthetic Joint Infection Using a 30-Item Accumulated Frailty Index in a 13,371-Patient Multicenter Cohort
Arthroplasty today, 14 Sept 2026
Advancing preoperative planning technology in total joint arthroplasty with a real-time machine learning calculator: 1-year mortality risk in a value-based care era
Arthroplasty (London, England), 9 Sept 2026
Incidence and associated outcomes of major adverse cardiovascular events in multiple sclerosis versus rheumatoid arthritis
Multiple sclerosis and related disorders, 4 Sept 2026
Combined GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapy for Adults with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease: A Large-Scale Target Trial Emulation
Research Square, 1 Sept 2026
GLP-1 agonist use and lower rates of pseudarthrosis and dysphagia following anterior cervical discectomy and fusion surgery, with time-dependent effects
Journal of neurosurgery. Spine, 28 Aug 2026
Association of semaglutide use with kidney outcomes in adults with ADPKD: A propensity score-matched real-world study
Science progress, 26 Aug 2026
Herpes Zoster Ophthalmicus and 3-Year Dementia Risk: Association and Modification by Prior Zoster Vaccination in a Large US Cohort
Cornea, 26 Aug 2026
Impact of Pre-injury Statin Use on Mortality and Short-Term Clinical Outcomes Following Intracerebral Hemorrhage: A Propensity-Matched Cohort Study
Cureus, 23 Aug 2026
Associations Between Glucagon-like Peptide-1 Receptor Agonists and Respiratory Outcomes in Chronic Obstructive pulmonary disease and Diabetes
QJM : monthly journal of the Association of Physicians, 17 Aug 2026
Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world active-comparator cohort study
Frontiers in pharmacology, 15 Aug 2026
Cardiovascular Outcomes of Tirzepatide vs Semaglutide in Obesity Without Type 2 Diabetes: A Matched Cohort Study
Research Square, 7 Aug 2026
Autoimmune Disease Risk With GLP-1RA, DPP-4i, and SGLT2i Treatment in Patients With Diabetes
ACR open rheumatology, 8 Jul 2026
HbA1c trajectories after SGLT2 inhibitor initiation and the risk of dementia
Journal of Alzheimer's disease : JAD, 7 Jul 2026
PCSK9 Inhibitors Are Associated with a Lower Risk of Incident Diabetes: A Global Real-World Analysis
ADA Scientific Sessions 2026 abstract, 7 Jun 2026